Research ArticlePediatric Rheumatology
Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis
Mojca Zajc Avramovič, Vita Dolžan, Nataša Toplak, Meta Accetto, Lara Lusa and Tadej Avčin
The Journal of Rheumatology August 2017, 44 (8) 1216-1223; DOI: https://doi.org/10.3899/jrheum.160950
Mojca Zajc Avramovič
From the Department of Allergology, Rheumatology and Clinical Immunology, Children’s Hospital, University Medical Centre Ljubljana; Institute of Biochemistry, and Department of Pediatrics, and Institute for Biostatistics and Medical Informatics, Medical Faculty, University of Ljubljana, Ljubljana,
Slovenia.
Vita Dolžan
Nataša Toplak
Meta Accetto
Lara Lusa
Tadej Avčin
Data supplements
Data Supplement
Files in this Data Supplement:
In this issue
The Journal of Rheumatology
Vol. 44, Issue 8
1 Aug 2017
Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis
Mojca Zajc Avramovič, Vita Dolžan, Nataša Toplak, Meta Accetto, Lara Lusa, Tadej Avčin
The Journal of Rheumatology Aug 2017, 44 (8) 1216-1223; DOI: 10.3899/jrheum.160950
Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis
Mojca Zajc Avramovič, Vita Dolžan, Nataša Toplak, Meta Accetto, Lara Lusa, Tadej Avčin
The Journal of Rheumatology Aug 2017, 44 (8) 1216-1223; DOI: 10.3899/jrheum.160950